by Payash Bahuguna | Nov 14, 2023 | Blog
Iktos has been mentioned in an article by L’Usine Nouvelle, expliaing how the convergence of data analysis, mathematical modeling, high-power computing, and artificial intelligence are digitizing health. Learn more by subscribing to the...
by Payash Bahuguna | Nov 14, 2023 | Blog
L’Usine Nouvelle has featured an article dedicated to Iktos: Embracing the powerful alliance of AI and chemistry, Iktos is revolutionizing drug discovery by compressing the traditional discovery phase from years to mere months. Subscribe here to learn more about this...
by Payash Bahuguna | Oct 5, 2023 | Blog
Iktos is thrilled to be listed as one of the 11 drug discovery startups to watch, according to VCs. Currently, getting a new drug to market can take between 10 and 15 years, but AI has the potential to speed it up! Read the full article...
by Payash Bahuguna | Oct 5, 2023 | Blog
My SIH Magazine has mentioned Iktos’s collaboration with Kissei Pharmaceutical in a recent article. This new partnership makes it possible to envisage the rapid and efficient design of new molecules of therapeutic interest as part of the drug discovery and...
by Payash Bahuguna | Sep 25, 2023 | Blog
Challenges puts Iktos in the spotlight. The French business magazine has produced a 15-page feature on the advances made by artificial intelligence in all activity sectors. In the healthcare sector, Challenges highlighted how “Iktos has developed a technology...
by Payash Bahuguna | Jun 22, 2023 | Blog
Le Figaro, a prominent French newspaper has published an article on ‘Generative artificial intelligence is already permeating all parts of the economy’ featuring Iktos as a world pioneer in AI-based drug discovery. Follow the link to this interesting...
